StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to “Buy”
West Pharmaceutical Services (NYSE:WST – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Other analysts ...
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day
Shares of West Pharmaceutical Services Inc. WST rallied 1.28% to $343.91 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 5 ...
West Pharmaceutical sets first-quarter dividend at $0.21/share
EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE:WST), a company specializing in solutions for injectable drug ...
WST, GXIG, STVN poised to benefit from Abbott's CGM growth
KeyBanc highlighted WST, GXIG, and STVN as the main beneficiaries following robust demand in the Continuous Glucose Monitoring (CGM) device market, as evidenced by Abbott Laboratories (NYSE:ABT)' ...